Scandinavian Humeral Diaphyseal Fracture Trial

NCT04574336 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 287

Last updated 2024-04-16

No results posted yet for this study

Summary

This pragmatic multicenter randomized controlled trial (RCT) includes adult participants with an acute humeral shaft fracture to compare surgical fixation of humeral shaft fracture to non-surgical treatment with early identification and treatment of delayed union by a patient-reported outcome after 52 weeks. The trial population of 287 participants The trial population is divided in two age-groups due to the changes in DASH score by age. The definition of delayed union differs in the young and elderly population to consider dissimilarity in bone healing rates and the timepoint for crossover is therefor different between the groups. Participants will be randomized 1:1 between non-surgical treatment and surgical treatment. The primary outcome is the Disability of Arm, Shoulder and Hand (DASH) score at 52 weeks, and is assessor blinded. The secondary outcomes are DASH score earlier than 52 weeks, EQ-5D-5L, pain assessed by visual analogue score, Constant-Murley score including elbow range of motion and anchor-questions collected at all timepoints throughout the trial. All complications will be reported including; infection, nerve or vascular injury, surgical revisions (implant malpositioning, hardware failure, aseptic loosening and peri-implant fracture), major adverse cardiovascular events, other major adverse events and mortality. SHAFT will provide information on the effectiveness of two standard treatments for humeral shaft fractures, while taking the dilemmas within the population into account.

Conditions

  • Fracture Humerus of Shaft

Interventions

PROCEDURE

Surgical treatment

We anticipate that surgical treatment will include plate osteosynthesis (MIPO and ORIF), intramedullary nailing (antegrade and retrograde) and external fixation. Plate and nail types, screw configuration and surgical approaches will be decided by the surgeon. The procedure will be conducted or supervised by a senior consultant.

DEVICE

Non-surgical treatment

Non-surgical treatment will include sugar tong, splint, plaster splints, hanging casts, or functional bracing as the Sarmiento brace and will be worn until a surgeon removes it. If the surgeon deems it appropriate, participants will be offered to undergo early secondary surgery with a surgical procedure of their choice. The participants will be recorded and the reason will be noted. We anticipate the surgical procedures will be similar to the previous mentioned and perhaps with the addition of bone graft.

Sponsors & Collaborators

  • Copenhagen University Hospital, Hvidovre

    collaborator OTHER
  • Zealand University Hospital

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Sahlgrenska University Hospital

    collaborator OTHER
  • Uppsala University Hospital

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Hospital of Southern Jutland

    collaborator OTHER
  • Slagelse Hospital

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • University Hospital, Umeå

    collaborator OTHER
  • Nordsjaellands Hospital

    collaborator OTHER
  • Holbaek Sygehus

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Copenhagen University Hospital at Herlev

    collaborator OTHER
  • University Hospital Bispebjerg and Frederiksberg

    collaborator OTHER
  • Viborg Regional Hospital

    collaborator OTHER
  • Karolinska University Hospital

    collaborator OTHER
  • Danderyd Hospital

    collaborator OTHER
  • Tampere University Hospital

    collaborator OTHER
  • Helsinki University Central Hospital

    collaborator OTHER
  • Kolding Sygehus

    lead OTHER

Principal Investigators

  • Bjarke Viberg, MD, PhD · Hospital Lillebaelt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2025-12-31
Completion
2031-07-31

Countries

  • Denmark
  • Finland
  • Norway
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04574336 on ClinicalTrials.gov